Concepedia

G. Rosenkranz

GR

Statistics

Publications

96

Citations

2.9K

H-Index

31

Active since

1948

Affiliations

Novartis (Switzerland)(Current)

Medical University of Vienna

Statistics Austria

G. Rosenkranz is an author at Novartis (Switzerland) specializing in pharmacology, biochemistry, and medicine.

ORCID

Top concepts

Publications per year

1948–2021

96

Publications

96

Steroids. LIV.<sup>1</sup> Synthesis of 19-Nov-17α-ethynyltestosterone and 19-Nor-17α-methyltestosterone<sup>2</sup>

Carl Djerassi, L. Miramontes, G. Rosenkranz et al. · Journal of the American Chemical Society · 1954 · 173 citations

, , +15

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study

Donald B. Bailey, Elizabeth Berry‐Kravis, Anne Wheeler et al. · Journal of Neurodevelopmental Disorders · 2015 · 99 citations · Full text

Steroids. IV.<sup>1a</sup> α-Iodoketones. A Method for the Conversion of Allosteroids into ▵<sup>4</sup>-3-Ketosteroids<sup>1b</sup>

G. Rosenkranz, O. Mancera, J. Gatica et al. · Journal of the American Chemical Society · 1950 · 88 citations

, , +13

Steroids. VII.<sup>1</sup> Contribution to the Bromination of ▵<sup>4</sup>-3-Ketosteroids and a New Partial Synthesis of the Natural Estrogens

Carl Djerassi, G. Rosenkranz, J. Romo et al. · Journal of the American Chemical Society · 1950 · 83 citations

, , +16

Steroids. LXXIII.<sup>1a</sup> The Direct Oppenauer Oxidation of Steroidal Formate Esters. A New Synthesis of 17α-Hydroxyprogesterone<sup>1b</sup>

Howard J. Ringold, Bjarte Löken, G. Rosenkranz et al. · Journal of the American Chemical Society · 1956 · 69 citations

, , +13

1–5 of 96